Browsing by Author "Barouta, G."
Now showing items 1-4 of 4
-
Mycophenolate mofetil in systemic sclerosis-associated interstitial lung disease
Koutroumpas, A.; Ziogas, A.; Alexiou, I.; Barouta, G.; Sakkas, L. I. (2010)This study aimed to assess the effect of mofetil mycophenolate (MMF), an inhibitor of lymphocyte proliferation, on lung function and skin in patients with systemic sclerosis (SSc)-associated interstitial lung disease ... -
Oral Tuberculosis in a Patient With Rheumatoid Arthritis After Long Treatment With Methotrexate and Adalimumab
Barouta, G.; Karapetsa, M.; Kostopoulou, E.; Alexiou, I.; Koukoulis, G.; Sakkas, L. I. (2010)The treatment of rheumatoid arthritis (RA) with tumor necrosis factor alpha (TNF-alpha) inhibitors has been associated with an increased risk of tuberculosis (TB). Most patients have extrapulmonary disease. We describe a ... -
THE PREVALENCE OF OSTEOARTHRITIS IN CENTRAL GREECE
Anagnostopoulos, I.; Zintzaras, E.; Alexiou, I.; Koutroumpas, A.; Papathanasiou, A.; Barouta, G.; Sakkas, L. (2009) -
The prevalence of rheumatic diseases in central Greece: a population survey
Anagnostopoulos, I.; Zinzaras, E.; Alexiou, I.; Papathanasiou, A. A.; Davas, E.; Koutroumpas, A.; Barouta, G.; Sakkas, L. I. (2010)Background: Rheumatic diseases are a major health and financial burden for societies. The prevalence of rheumatic diseases may change over time, and therefore, we sought to estimate the prevalence of rheumatic diseases in ...